Cue Biopharma, Inc. (CUE) Tops Q3 EPS by 2c

Cue Biopharma, Inc. (NASDAQ: CUE) reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $2.15 million versus the consensus estimate of $2.93 million.

For earnings history and earnings-related data on Cue Biopharma, Inc. (CUE) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14